Public recall detail

Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns

2024-09-16

medium
Recall Safety notice
Quick summary

Quick summary: Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns. Date: 2024-09-16.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns. Date: 2024-09-16.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandRefresh
ProductRefresh Lacri-Lube Ophthalmic ointment
IssueHealth products - Product quality
Recall classType II
IdentificationRA-76044

Affected products

BrandRefresh
ProductRefresh Lacri-Lube Ophthalmic ointment
DIN / NPN / authorizationDIN 00210889
Dosage formOintment
StrengthMineral oil 42.5% White petrolatum 57.3%
Lot397281, 399002, 399923, 409826

Issue

Product sterility may be compromised in affected lots due to the possibility of leakage.

What you should do

  • Do not use the affected product. Return it to your local pharmacy for proper disposal.
  • Seek medical attention if you have used this product and are experiencing signs of infection, such as eye pain and discharge, fever, or facial pain or pressure.
  • Consult a health care professional if you have used this product and have health concerns.
  • Contact AbbVie Corporation of Canada by calling 1-888-704-8270 or emailing service@abbvie.com if you have questions about this recall.
  • Report any health product-related side effects or complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesAbbvie Corporation 8401 Trans-Canada Highway, Saint-Laurent, Quebec, H4S 1Z1
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-76044
Background{}
CompaniesAbbvie Corporation 8401 Trans-Canada Highway, Saint-Laurent, Quebec, H4S 1Z1
AudiencesGeneral public Healthcare Industry
Source updated2024-09-16

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...